EHC — Encompass Health Corporation

Encompass Health (EHC) Q3 2025 Earnings Call Summary

1. Key Financial Results and Metrics

• Revenue: Increased by 9.4% year-over-year to $1.3 billion.
• Adjusted EBITDA: Grew 11.4% to $300.1 million, with a year-to-date increase of 14.5%.
• Adjusted Free Cash Flow: Decreased 8.2% to $174.2 million, primarily due to a $55.8 million increase in working capital. Year-to-date free cash flow rose 16.5% to $582.5 million.
• Net Leverage: Remained stable at 2x.
• Turnover Rates: Annualized RN turnover at 20.2% and therapist turnover at 7.8%, consistent with favorable trends from the previous year.

2. Strategic Updates and Business Highlights

• Quality Metrics: Q3 discharge community rate was 84.6%, with discharge to acute and SNF rates at 8.6% and 6%, respectively, exceeding industry averages.
• New Openings: Opened three new hospitals in Q3 and plans to open two more in Q4, with a total of 14 hospitals in the pipeline beyond 2025.
• Investment in Staff: Continued investment in clinical staff development, contributing to favorable turnover rates.
• ERP System Conversion: Successfully transitioned to Oracle Fusion on October 3, with no significant operational disruptions noted.

3. Forward Guidance and Outlook

• 2025 Guidance: Increased expectations for net operating revenue to $5.905 billion - $5.955 billion, adjusted EBITDA to $1.235 billion - $1.255 billion, and adjusted earnings per share to $5.22 - $5.37.
• Bed Additions: Increased expected bed additions to approximately 127 for 2025, with plans for 150-200 in 2026 and 2027.

4. Bad News, Challenges, or Points of Concern

• Volume Growth Fluctuations: Q3 saw a 5% increase in total discharges, but the company noted fluctuations in discharge volume growth due to various factors, including the consolidation of satellite locations which negatively impacted growth by approximately 35 basis points.
• Increased Working Capital: The rise in working capital impacted free cash flow, although it is expected to normalize in Q4.
• Regulatory Risks: Ongoing monitoring of Medicare Advantage dynamics and potential impacts from regulatory changes, although no immediate concerns were reported.

5. Notable Q&A Insights

• Future Volume Growth: Management expressed optimism about future volume growth driven by increased bed additions and the unmet demand for inpatient rehabilitation services.
• Payer Mix Stability: The payer mix remained balanced, with growth across Medicare, Medicare Advantage, and managed care, indicating resilience despite potential shifts in the Medicare landscape.
• Occupancy Rates: Expected fluctuations in occupancy rates due to timing of new hospital openings and seasonal factors, with potential downward pressure in Q1 2026.
• Labor Management: Continued success in managing labor costs, with a noted decrease in premium labor expenses and improved hiring metrics.

Overall, EHC's Q3 2025 results reflect strong financial performance and strategic growth initiatives, although challenges related to volume fluctuations and regulatory dynamics remain.